Rep. Mike Fitzpatrick, R-Pa., has asked FDA's criminal division to investigate Ethicon Inc.'s conduct in marketing power morcellators that have been linked to the spread of undiagnosed cancers in women undergoing treatment for uterine fibroids.
In a Dec. 18 letter
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?